Pricing Log in Create free account

Eikon Therapeutics, Inc. (EIKN) vs ProKidney Corp. (PROK)

Eikon Therapeutics, Inc. and ProKidney Corp. are both Biotechnology companies. Eikon Therapeutics, Inc. and ProKidney Corp. are of similar size ($322.0M and $316.3M). Eikon Therapeutics, Inc. has the higher net margin (0.00% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Eikon Therapeutics, Inc. leads on 5 and ProKidney Corp. on 5.

Valuation

Metric EIKN PROK Biotechnology median
P/E n/m n/m 10.60
P/S n/m 262.28 9.40
P/B 0.69 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.62 n/m 0.66
EV/Sales n/m 40.72 9.02
Earnings yield (1,147.55%) (47.83%) (32.88%)
Free cash flow yield (138.83%) (65.96%) (23.13%)

Profitability

Metric EIKN PROK Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (21,664.55%) 0.00%
Net margin 0.00% (10,288.39%) 0.00%
Free cash flow margin 0.00% (17,300.61%) 0.00%
Return on equity 0.00% 8.92% (51.96%)
Return on assets (90.08%) (27.10%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EIKN PROK Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (19.15%) 16.13% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EIKN PROK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.89 8.36 4.97
Net debt to EBITDA 1.07 1.70 1.01

Dividend

Metric EIKN PROK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EIKN PROK Biotechnology median
Market cap 316.32m 322.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack